‌

US Patent 12110311 Cyclic deoxyribonucleotide compounds

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Lin Zhi0

Date of Patent

October 8, 2024

0

Patent Application Number

176254980

Date Filed

July 15, 2020

0

Patent Citations

US Patent 11427550 5-fluorouracil compounds

0

US Patent 11566041 Nucleotide prodrug compounds

0

US Patent 7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections

0

US Patent 8097706 Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein

0

US Patent 8603999 Amphiphile prodrugs

0

US Patent 8653048 Prodrugs based on gemcitabine structure and synthetic methods and applications thereof

0

US Patent 8741858 Oligomer-nucleoside phosphate conjugates

0

US Patent 9447137 Substituted gemcitabine aryl amide analogs

0

...

Patent Primary Examiner

Patrick T. Lewis

0

Patent abstract

Provided herein are 5-fluorouracil derived cyclic deoxyribonucleotide compounds, their preparation and their uses, such as treating liver diseases or various types of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12110311 Cyclic deoxyribonucleotide compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.